The global CRISPR Market, valued at US$2.90 billion in 2024, is forecasted to grow at a robust CAGR of 11.2%, reaching US$3.21 billion in 2025 and an impressive US$5.47 billion by 2030. The growing ...

Bactana Corp., a research-driven biotechnology company developing groundbreaking advancements in anaerobic bacteria isolation and fermentation, today announced it has agreed to be acquired by Kemin ...